Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer (NSCLC) Stages IIIB/IV

NCT00516685 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

230

Enrollment

INDUSTRY

Sponsor class

Stopped Due to inability of patient enrollment, decision taken to terminate in the interests of patients and later Malaysia is incorporated into global Phase 3 trial.

Conditions

Non-small-cell Lung Cancer (NSCLC) Stage IIIb/IV

Interventions

BIOLOGICAL: Recombinant Human rEGF-P64K/Montanide Vaccine

Sponsor

Bioven Sdn. Bhd.